1-20 of 132
subcutaneous insulin delivery
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Carbohydrate Requirements for Prolonged, Fasted Exercise With and Without Basal Rate Reductions in Adults With Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion

Sarah M. McGaugh, Dessi P. Zaharieva, Rubin Pooni, Ninoschka C. D’Souza, Todd Vienneau, Trang T. Ly, Michael C. Riddell
Journal: Diabetes Care
Diabetes Care 2021;44(2):610–613
https://doi.org/10.2337/dc20-1554
Published: 16 December 2020
View article titled, Carbohydrate Requirements for Prolonged, Fasted Exercise With and Without Basal Rate Reductions in Adults With Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion
Open the PDF for Carbohydrate Requirements for Prolonged, Fasted Exercise With and Without Basal Rate Reductions in Adults With Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion in another window
Journal Articles

9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2020

American Diabetes Association
Journal: Diabetes Care
Diabetes Care 2020;43(Supplement_1):S98–S110
https://doi.org/10.2337/dc20-S009
Published: 16 December 2019
View article titled, 9. Pharmacologic Approaches to Glycemic Treatment: <em>Standards of Medical Care in Diabetes—2020</em>
Open the PDF for 9. Pharmacologic Approaches to Glycemic Treatment: <em>Standards of Medical Care in Diabetes—2020</em> in another window
Journal Articles

Improved Open-Loop Glucose Control With Basal Insulin Reduction 90 Minutes Before Aerobic Exercise in Patients With Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion

Dessi P. Zaharieva, Sarah McGaugh, Rubin Pooni, Todd Vienneau, Trang Ly, Michael C. Riddell
Journal: Diabetes Care
Diabetes Care 2019;42(5):824–831
https://doi.org/10.2337/dc18-2204
Published: 22 February 2019
View article titled, Improved Open-Loop Glucose Control With Basal Insulin Reduction 90 Minutes Before Aerobic Exercise in Patients With Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion
Open the PDF for Improved Open-Loop Glucose Control With Basal Insulin Reduction 90 Minutes Before Aerobic Exercise in Patients With Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion in another window
Includes: Supplementary data
Journal Articles

Response to Comment on Russell-Jones et al. Diabetes Care 2017;40:943–950. Comment on Bowering et al. Diabetes Care 2017;40:951–957

Bruce W. Bode, Keith Bowering, David Russell-Jones
Journal: Diabetes Care
Diabetes Care 2018;41(3):e29–e30
https://doi.org/10.2337/dci17-0051
Published: 12 February 2018
View article titled, Response to Comment on Russell-Jones et al. Diabetes Care 2017;40:943–950. Comment on Bowering et al. Diabetes Care 2017;40:951–957
Open the PDF for Response to Comment on Russell-Jones et al. Diabetes Care 2017;40:943–950. Comment on Bowering et al. Diabetes Care 2017;40:951–957 in another window
Journal Articles

Glycemic Control During Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Insulin Injections in Type 2 Diabetes: Individual Patient Data Meta-analysis and Meta-regression of Randomized Controlled Trials

John C. Pickup, Yves Reznik, Alex J. Sutton
Journal: Diabetes Care
Diabetes Care 2017;40(5):715–722
https://doi.org/10.2337/dc16-2201
Published: 12 April 2017
View article titled, Glycemic Control During Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Insulin Injections in Type 2 Diabetes: Individual Patient Data Meta-analysis and Meta-regression of Randomized Controlled Trials
Open the PDF for Glycemic Control During Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Insulin Injections in Type 2 Diabetes: Individual Patient Data Meta-analysis and Meta-regression of Randomized Controlled Trials in another window
Journal Articles

Blinded Continuous Glucose Monitoring During Yom Kippur Fasting in Patients With Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion Therapy

Muriel Metzger, Lisa Lederhendler, Asher Corcos
Journal: Diabetes Care
Diabetes Care 2015;38(3):e34–e35
https://doi.org/10.2337/dc14-1874
Published: 12 February 2015
View article titled, Blinded Continuous Glucose Monitoring During Yom Kippur Fasting in Patients With Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion Therapy
Open the PDF for Blinded Continuous Glucose Monitoring During Yom Kippur Fasting in Patients With Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion Therapy in another window
Journal Articles

Corneal Confocal Microscopy Shows an Improvement in Small-Fiber Neuropathy in Subjects With Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion Compared With Multiple Daily Injection

Shazli Azmi, Maryam Ferdousi, Ioannis N. Petropoulos, Georgios Ponirakis, Hassan Fadavi, Mitra Tavakoli, Uazman Alam, Wendy Jones, Andrew Marshall, Maria Jeziorska, Andrew J.M. Boulton, Nathan Efron, Rayaz A. Malik
Journal: Diabetes Care
Diabetes Care 2015;38(1):e3–e4
https://doi.org/10.2337/dc14-1698
Published: 13 December 2014
View article titled, Corneal Confocal Microscopy Shows an Improvement in Small-Fiber Neuropathy in Subjects With Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion Compared With Multiple Daily Injection
Open the PDF for Corneal Confocal Microscopy Shows an Improvement in Small-Fiber Neuropathy in Subjects With Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion Compared With Multiple Daily Injection in another window
Journal Articles

Clinical Characteristics and Outcome of 467 Patients With a Clinically Recognized Eating Disorder Identified Among 52,215 Patients With Type 1 Diabetes: A Multicenter German/Austrian Study

Nicole Scheuing, Béla Bartus, Gabriele Berger, Holger Haberland, Andrea Icks, Burkhild Knauth, Nicole Nellen-Hellmuth, Joachim Rosenbauer, Martin Teufel, Reinhard W. Holl, on behalf of the DPV Initiative, the German BMBF Competence Network Diabetes Mellitus
Journal: Diabetes Care
Diabetes Care 2014;37(6):1581–1589
https://doi.org/10.2337/dc13-2156
Published: 10 May 2014
View article titled, Clinical Characteristics and Outcome of 467 Patients With a Clinically Recognized Eating Disorder Identified Among 52,215 Patients With Type 1 Diabetes: A Multicenter German/Austrian Study
Open the PDF for Clinical Characteristics and Outcome of 467 Patients With a Clinically Recognized Eating Disorder Identified Among 52,215 Patients With Type 1 Diabetes: A Multicenter German/Austrian Study in another window
Includes: Supplementary data
Journal Articles

Day and Night Closed-Loop Control in Adults With Type 1 Diabetes: A comparison of two closed-loop algorithms driving continuous subcutaneous insulin infusion versus patient self-management

Yoeri M. Luijf, PHD, J. Hans DeVries, PHD, Koos Zwinderman, PHD, Lalantha Leelarathna, MRCP, Marianna Nodale, MSC, Karen Caldwell, RN, Kavita Kumareswaran, PHD, Daniela Elleri, MD, Janet M. Allen, RN, Malgorzata E. Wilinska, PHD, Mark L. Evans, MD, Roman Hovorka, PHD, Werner Doll, MS, Martin Ellmerer, PHD, Julia K. Mader, MD, Eric Renard, PHD, Jerome Place, MS, Anne Farret, MD, Claudio Cobelli, PHD, Simone Del Favero, PHD, Chiara Dalla Man, PHD, Angelo Avogaro, PHD, Daniela Bruttomesso, PHD, Alessio Filippi, MD, Rachele Scotton, MD, Lalo Magni, PHD, Giordano Lanzola, PHD, Federico Di Palma, PHD, Paola Soru, MS, Chiara Toffanin, MS, Giuseppe De Nicolao, PHD, Sabine Arnolds, MD, Carsten Benesch, PHD, Lutz Heinemann, PHD, on behalf of the AP@home Consortium
Journal: Diabetes Care
Diabetes Care 2013;36(12):3882–3887
https://doi.org/10.2337/dc12-1956
Published: 13 November 2013
View article titled, Day and Night Closed-Loop Control in Adults With Type 1 Diabetes: <subtitle>A comparison of two closed-loop algorithms driving continuous subcutaneous insulin infusion versus patient self-management</subtitle>
Open the PDF for Day and Night Closed-Loop Control in Adults With Type 1 Diabetes: <subtitle>A comparison of two closed-loop algorithms driving continuous subcutaneous insulin infusion versus patient self-management</subtitle> in another window
Includes: Supplementary data
Journal Articles

Use of an Insulin Bolus Advisor Improves Glycemic Control in Multiple Daily Insulin Injection (MDI) Therapy Patients With Suboptimal Glycemic Control: First results from the ABACUS trial

Ralph Ziegler, MD, David A. Cavan, MD, Iain Cranston, MD, Katharine Barnard, CPSYCHOL, Jacqueline Ryder, RGN, Claudia Vogel, DDB, Christopher G. Parkin, MS, Walter Koehler, MS, Iris Vesper, MS, Bettina Petersen, PHD, Matthias A. Schweitzer, MD, Robin S. Wagner, DVM
Journal: Diabetes Care
Diabetes Care 2013;36(11):3613–3619
https://doi.org/10.2337/dc13-0251
Published: 15 October 2013
View article titled, Use of an Insulin Bolus Advisor Improves Glycemic Control in Multiple Daily Insulin Injection (MDI) Therapy Patients With Suboptimal Glycemic Control: <subtitle>First results from the ABACUS trial</subtitle>
Open the PDF for Use of an Insulin Bolus Advisor Improves Glycemic Control in Multiple Daily Insulin Injection (MDI) Therapy Patients With Suboptimal Glycemic Control: <subtitle>First results from the ABACUS trial</subtitle> in another window
Journal Articles

Insulin Pump for Type 2 Diabetes: Use and misuse of continuous subcutaneous insulin infusion in type 2 diabetes

Yves Reznik, MD, Ohad Cohen, MD
Journal: Diabetes Care
Diabetes Care 2013;36(Supplement_2):S219–S225
https://doi.org/10.2337/dcS13-2027
Published: 17 July 2013
View article titled, Insulin Pump for Type 2 Diabetes: <subtitle>Use and misuse of continuous subcutaneous insulin infusion in type 2 diabetes</subtitle>
Open the PDF for Insulin Pump for Type 2 Diabetes: <subtitle>Use and misuse of continuous subcutaneous insulin infusion in type 2 diabetes</subtitle> in another window
Journal Articles

Attitudes Toward Diabetes Affect Maintenance of Drug-Free Remission in Patients With Newly Diagnosed Type 2 Diabetes After Short-Term Continuous Subcutaneous Insulin Infusion Treatment

Ailing Chen, MN, Zhimin Huang, MD, Xuesi Wan, MD, Wanping Deng, BSN, Jiyan Wu, BSN, Licheng Li, BSN, Qiuling Cai, BSN, Haipeng Xiao, MD, Yanbing Li, MD
Journal: Diabetes Care
Diabetes Care 2012;35(3):474–481
https://doi.org/10.2337/dc11-1638
Published: 10 February 2012
View article titled, Attitudes Toward Diabetes Affect Maintenance of Drug-Free Remission in Patients With Newly Diagnosed Type 2 Diabetes After Short-Term Continuous Subcutaneous Insulin Infusion Treatment
Open the PDF for Attitudes Toward Diabetes Affect Maintenance of Drug-Free Remission in Patients With Newly Diagnosed Type 2 Diabetes After Short-Term Continuous Subcutaneous Insulin Infusion Treatment in another window
Journal Articles

Use of Continuous Glucose Monitoring in Subjects With Type 1 Diabetes on Multiple Daily Injections Versus Continuous Subcutaneous Insulin Infusion Therapy: A prospective 6-month study

Satish K. Garg, MD, Mary K. Voelmle, MS, Christie R. Beatson, RD, Hayley A. Miller, MD, Lauren B. Crew, BS, Brandon J. Freson, BS, Rachel M. Hazenfield, BA
Journal: Diabetes Care
Diabetes Care 2011;34(3):574–579
https://doi.org/10.2337/dc10-1852
Published: 17 February 2011
View article titled, Use of Continuous Glucose Monitoring in Subjects With Type 1 Diabetes on Multiple Daily Injections Versus Continuous Subcutaneous Insulin Infusion Therapy: <subtitle>A prospective 6-month study</subtitle>
Open the PDF for Use of Continuous Glucose Monitoring in Subjects With Type 1 Diabetes on Multiple Daily Injections Versus Continuous Subcutaneous Insulin Infusion Therapy: <subtitle>A prospective 6-month study</subtitle> in another window
Journal Articles

Errata

Journal: Diabetes Care
Diabetes Care 2009;32(10):1944
https://doi.org/10.2337/dc09-er10
Published: 01 October 2009
View article titled, Errata
Open the PDF for Errata in another window
Journal Articles

Comparison of a Multiple Daily Insulin Injection Regimen (Basal Once-Daily Glargine Plus Mealtime Lispro) and Continuous Subcutaneous Insulin Infusion (Lispro) in Type 1 Diabetes: A randomized open parallel multicenter study

Geremia B. Bolli, MD, David Kerr, MD, Reena Thomas, MD, Elisabetta Torlone, MD, Agnès Sola-Gazagnes, MD, Ester Vitacolonna, MD, Jean Louis Selam, MD, Philip D. Home, DM, DPHIL
Journal: Diabetes Care
Diabetes Care 2009;32(7):1170–1176
https://doi.org/10.2337/dc08-1874
Published: 23 April 2009
View article titled, Comparison of a Multiple Daily Insulin Injection Regimen (Basal Once-Daily Glargine Plus Mealtime Lispro) and Continuous Subcutaneous Insulin Infusion (Lispro) in Type 1 Diabetes: <subtitle>A randomized open parallel multicenter study</subtitle>
Open the PDF for Comparison of a Multiple Daily Insulin Injection Regimen (Basal Once-Daily Glargine Plus Mealtime Lispro) and Continuous Subcutaneous Insulin Infusion (Lispro) in Type 1 Diabetes: <subtitle>A randomized open parallel multicenter study</subtitle> in another window
Includes: Supplementary data
Journal Articles

No Apparent Local Effect of Insulin on Microdialysis Continuous Glucose- Monitoring Measurements

Jeroen Hermanides, MD, Iris M. Wentholt, MD, Augustinus A. Hart, PHD, Joost B. Hoekstra, MD, PHD, J. Hans DeVries, MD, PHD
Journal: Diabetes Care
Diabetes Care 2008;31(6):1120–1122
https://doi.org/10.2337/dc08-0145
Published: 01 June 2008
View article titled, No Apparent Local Effect of Insulin on Microdialysis Continuous Glucose- Monitoring Measurements
Open the PDF for No Apparent Local Effect of Insulin on Microdialysis Continuous Glucose- Monitoring Measurements in another window
Includes: Supplementary data
Journal Articles

Quantifying the Impact of a Short-Interval Interruption of Insulin-Pump Infusion Sets on Glycemic Excursions

Howard Zisser, MD
Journal: Diabetes Care
Diabetes Care 2008;31(2):238–239
https://doi.org/10.2337/dc07-1757
Published: 01 February 2008
View article titled, Quantifying the Impact of a Short-Interval Interruption of Insulin-Pump Infusion Sets on Glycemic Excursions
Open the PDF for Quantifying the Impact of a Short-Interval Interruption of Insulin-Pump Infusion Sets on Glycemic Excursions in another window
Journal Articles

A Randomized Trial Comparing Continuous Subcutaneous Insulin Infusion of Insulin Aspart Versus Insulin Lispro in Children and Adolescents With Type 1 Diabetes

Stuart A. Weinzimer, MD, Christine Ternand, MD, Campbell Howard, MD, Cheng-Tao Chang, PHD, Dorothy J. Becker, MB, BCH, Lori M.B. Laffel, MD, MPH, for the Insulin Aspart Pediatric Pump Study Group
Journal: Diabetes Care
Diabetes Care 2008;31(2):210–215
https://doi.org/10.2337/dc07-1378
Published: 01 February 2008
View article titled, A Randomized Trial Comparing Continuous Subcutaneous Insulin Infusion of Insulin Aspart Versus Insulin Lispro in Children and Adolescents With Type 1 Diabetes
Open the PDF for A Randomized Trial Comparing Continuous Subcutaneous Insulin Infusion of Insulin Aspart Versus Insulin Lispro in Children and Adolescents With Type 1 Diabetes in another window
Journal Articles

Factors Correlating With Improved A1C in Children Using Continuous Subcutaneous Insulin Infusion

Jennifer J.F. McVean, MD, Jens C. Eickhoff, PHD, Michael J. MacDonald, MD
Journal: Diabetes Care
Diabetes Care 2007;30(10):2499–2500
https://doi.org/10.2337/dc07-0614
Published: 01 October 2007
View article titled, Factors Correlating With Improved A1C in Children Using Continuous Subcutaneous Insulin Infusion
Open the PDF for Factors Correlating With Improved A1C in Children Using Continuous Subcutaneous Insulin Infusion in another window
Journal Articles

Postprandial Hyperglycemia Is Associated With an Increase of Blood Pressure in Type 1 Diabetic Patients Treated With Continuous Subcutaneous Insulin Infusion

Giuseppe Lepore, MD, Anna Corsi, MD, Alessandro R. Dodesini, MD, Italo Nosari, MD, Roberto Trevisan, MD, PHD
Journal: Diabetes Care
Diabetes Care 2007;30(7):e60
https://doi.org/10.2337/dc07-0503
Published: 01 July 2007
View article titled, Postprandial Hyperglycemia Is Associated With an Increase of Blood Pressure in Type 1 Diabetic Patients Treated With Continuous Subcutaneous Insulin Infusion
Open the PDF for Postprandial Hyperglycemia Is Associated With an Increase of Blood Pressure in Type 1 Diabetic Patients Treated With Continuous Subcutaneous Insulin Infusion in another window